Consensus $480.8M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos reports Q2 EPS (24c), consensus (26c)
- Notable companies reporting after market close
- Glaukos price target raised to $117 from $114 at BTIG
- Glaukos announces E.U. MDR certification for iStent infinite
- Glaukos Positioned for Growth with Innovative Epioxa Therapy and First-Mover Advantage in Keratoconus Treatment